Search results
Results from the WOW.Com Content Network
Bharat Biotech has its manufacturing facility situated at Genome Valley, Hyderabad, India. [5] As of July 2020, the company has over 700 employees [6] and has a presence worldwide. [5] The company has been responsible for developing an eco-friendly recombinant [7] and a naturally attenuated strain derived Rotavirus vaccine called ROTAVAC.
Bharat Biotech [2] Brightcom Group; Cyient; Central Institute of Tool Design; Deccan chronicle; Divi's Laboratories [3] Dr. Reddy's Laboratories [4] Electronics Corporation of India; ETV Network; Glenmark Pharmaceuticals; GMR Group; GVK [5] Heritage Foods [6] Hetero Drugs; Indian Drugs and Pharmaceuticals (IDPL) Indian Immunologicals Limited [7]
The product is in line with the recommendations of the WHO. The product is produced with technology transfer from Nutriset through the Department of Biotechnology, Ministry of Science and Technology, Government of India. The Nutriset product has been tested in Indian fields and clinical trials have evaluated the efficacy of zinc supplementation ...
Bharat Aluminium Company: Basic materials Aluminium New Delhi: 1965 Aluminium, part of Vedanta Resources (UK) P A Bharat Biotech: Health care Pharmaceuticals & biotechnology Hyderabad: 1996 Drug development & vaccines P A Bharat Dynamics Limited: Industrials Aerospace & defense Hyderabad: 1970 State-owned missiles, defense S A Bharat ...
Genome Valley was commissioned by the then combined Government Andhra Pradesh in 1999 as S. P. Biotech Park in a public-private partnership with Bharat Biotech International, and its founder Krishna Ella, alongside private infrastructure companies such as Shapoorji Pallonji Group and ICICI Bank. [7]
India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a year amid an expanding ...
India's science minister launched a program that provides tax incentives and grants for biotech start-ups and firms seeking to expand and establishes the Biotechnology Parks Society of India to support ten biotech parks by 2010. Previously limited to rodents, animal testing was expanded to include large animals as part of the minister's initiative.
A vial of Covaxin used at a private hospital in Bengaluru, India. On 6 December 2020, Bharat Biotech applied to the Drugs Controller General of India (DCGI), seeking emergency use authorisation. [60] It was the third firm after Serum Institute of India and Pfizer to apply under such provision. [61]